The largest database of trusted experimental protocols

Spe ma10avp

Manufactured by Shimadzu
Sourced in Japan

The SPE-MA10AVP is a solid-phase extraction (SPE) workstation designed for automated sample preparation. It features a compact design and is capable of handling up to 10 samples simultaneously. The core function of this product is to automate the SPE process, allowing for improved efficiency and reproducibility in sample preparation tasks.

Automatically generated - may contain errors

7 protocols using spe ma10avp

1

Nanoparticle ACE Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The capacity of the nanoparticles to inhibit angiotensin I-converting enzyme (ACE) was determined by liquid chromatography (RP-HPLC) according to Alemán et al. [27 (link)], with some modifications. The reaction was composed of 50 µL of 5 mM Hippuryl-L-Histidyl-L-Leucine (HHL), 80 µL of ACE (0.025 U/mL) and 20 µL of samples and after incubation; the reaction was stopped by adding 80 µL of HCl (0.1 M). Then, 50 µL of each sample was injected in a RP-HPLC system (Shimadzu SPE-MA10AVP, Kyoto, Japan) using a flow rate of 0.8 mL/min and acetonitrile gradient from 20% to 60% in 0.1% (v/v) of trifluoroacetic acid in 26 min. The results were expressed as a percentage (%) of ACE-inhibitory activity.
+ Open protocol
+ Expand
2

ACE Inhibition Assay for Antihypertensive Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antihypertensive capacity was measured according to the angiotensin-converting enzyme (ACE) inhibition method described by Alemán et al. 16 using a High Performance Liquid Chromatography analyser (HPLC, model SPE-MA10AVP, Shimadzu, Kyota, Japan). All samples were dissolved in ultrapure Milli-Q water at 0.8 mg mL -1 . The results were expressed as the percentage of ACE-inhibitory activity.
+ Open protocol
+ Expand
3

Profiling Phenolic Compounds in Digests

Check if the same lab product or an alternative is used in the 5 most similar protocols
The profile of phenolic compounds in both FE and L-FE samples was determined before and after simulated gastrointestinal digestion (GID). In this regard, a middle step immediately after gastric digestion (GD) was also considered. The chlorogenic acid quantification was conducted in FE, L-FE, digest, and Caco-2 cells permeate samples. Analyses were performed by reverse-phase high-performance liquid chromatography (RP-HPLC, model SPE-MA10AVP, Shimadzu, Kyoto, Japan) on a C18 analytical column, following the procedure described in Alemán et al. [1 (link)].
+ Open protocol
+ Expand
4

ACE Inhibitory Activity of Yogurt

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of the sample to inhibit the angiotensin-converting enzyme (ACE) was determined according to Alemán et al. [33 (link)], with some modifications. The reaction was composed of 50 µL of 5 mM Hipuryl-histidyl-leucine (HHL), 80 µL of ACE (0.025 U/mL) and 20 µL of the yogurt supernatant (diluted 1:5 in 100 mM potassium phosphate buffer, containing 300 mM NaCl, pH 8.3). The determination was performed by reverse phase High Performance Liquid Chromatography (RP-HPLC) (model SPE-MA10AVP, Shimadzu, Kyoto, Japan). The injection volume was 50 µL and the flow rate 0.8 mL/ min, using an acetonitrile gradient from 20% to 60% in 0.1% trifluoroacetic acid (TFA) (v/v) for 26 min. The results were expressed as % of ACE-inhibitory activity.
+ Open protocol
+ Expand
5

Size-Exclusion Chromatography of Shrimp Protein Hydrolysate

Check if the same lab product or an alternative is used in the 5 most similar protocols
The molecular weight distribution of shrimp protein hydrolysate was evaluated by size-exclusion chromatography (HPLC model SPE-MA10AVP, Shimadzu, Kyoto, Japan), by using a Superdex peptide PC 3.2/30 column (GE Healthcare Bio-Sciences, Barcelona, Spain) with a fractionation range between 7.0 and 0.1 kDa. An amount of 10 mg of powdered hydrolysates was dissolved in Milli-Q water, centrifuged at 9000xg for 5 min, and filtered at 0.45 µm for removing contaminants before injection.
The injection volume was 10 µL and the flow rate was 0.1 mL/min. The mobile phase used was acetonitrile in Milli-Q water (30%, v/v) with 0.1% (v:v) trifluoroacetic acid.
Absorbance was monitored at 214 nm. Molecular weight standards including bovine serum albumin (6.64 kDa), aprotinin (6.511 kDa), vitamin B12 (1.355 kDa), angiotensin II (1.046 kDa), HHL (0.429 kDa) and glycine (0.075 kDa) were run through the column at the same condition and used for MW calculation. Plots of retention time for molecular weight standards were used to construct calibration curve, from which the hydrolysate molecular distribution were computed.
+ Open protocol
+ Expand
6

HPLC Analysis of Phenolic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
To identify the main phenolic compounds, the dried extracts and liposomal preparations (with and without Triton X-100) were dispersed in Milli-Q water and analysed by reverse phase high performance liquid chromatography (RP-HPLC; model SPE-MA10AVP, Shimadzu, Kyoto, Japan) on a C18 analytical column (Tracer Excel 120 ODS-A 5 μm 25 × 0.46, Teknokroma, Barcelona, Spain). The samples were eluted with a gradient system consisting of solvent A (MilliQ water) and solvent B (methanol:acetonitrile, 60:40), both containing 1% acetic acid, at a flow rate of 0.6 mL/min. The temperature of the column was maintained at 25 °C, and the injection volume was 20 μL. The gradient system started at 10% solvent B and increased to 60% B over 60 min, followed by a further decrease to 10% solvent A over 10 min. The final conditions were held for 10 min. The peaks of the phenolic compounds were monitored by absorbance at 253 nm and 368 nm. The identification of phenolic compounds was carried out by comparison of the retention times of the pure external standards listed above. Chlorogenic acid, vitamin C, rutin and rosmarinic acid were quantified using a calibration curve of the corresponding standard compound. Analyses were carried out at least in duplicate.
+ Open protocol
+ Expand
7

Molecular Weight Distribution of Hydrolysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
For overall molecular weight (MW) distribution of A20 and P20 hydrolysates, size exclusion high-performance liquid chromatography (Shimadzu, SPE-MA10AVP, Kyoto, Japan) was conducted, according to Sila et al. (2015) , using a Superdex Peptide PC 3.2/30 column (GE Healthcare Bio-Sciences, Barcelona, Spain), with a 1007000 Da separation range. The hydrolysate (10 µL) was loaded onto the column and eluted at 2.5 µL/min flow rate, using acetonitrile (30%; v/v) with trifluoroacetic acid (0.01%; v/v) as the mobile phase. MW standards used were glycine (75 Da), hippuryl-L-histidyl-L-leucine (429 Da), vitamin B12 (1340 Da), aprotinin (6512 Da) and bovine serum albumin (6700 Da). Optical density was monitored at 214 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!